Truist Financial (TFC) has seen significant share price appreciation over the past year, returning 26.9%. Despite this run, a Simply Wall St analysis suggests the stock is currently undervalued by 34.4% based on an Excess Returns model, which estimates an intrinsic value of $75.30 per share compared to its recent price of $49.43. Additionally, its current P/E ratio of 11.86x is below its calculated Fair Ratio of 13.12x, further indicating potential undervaluation.

TIAA Trust National Association reduced its stake in Southern Company by 65% in the fourth quarter, selling over 134,000 shares to hold 72,284 shares valued at $6.30 million. Southern Company reported stronger-than-expected quarterly earnings of $1.32 EPS and an 8% increase in revenue year-over-year, alongside raising its quarterly dividend to $0.76. Insider sales by EVP Christopher Cummiskey and CEO Kimberly S. Greene were also noted, totaling over $3 million, while analysts' ratings for Southern Company are predominantly "Hold" with an average price target of $99.38.

Parabilis Medicines successfully raised $670 million in an above-range initial public offering, selling 33.5 million shares at $20 each. The company also secured an additional $75 million through a concurrent private placement with Regeneron Pharmaceuticals, totaling approximately $745 million in gross proceeds. This funding will advance its Helicon discovery platform, which engineers stabilized helical peptides to target traditionally undruggable intracellular proteins, with its lead program, zolucatetide, focusing on the Wnt/beta-catenin signaling pathway for cancer treatment.

The article warns investors that Stryker (SYK) stock exhibits significantly higher implied volatility (32.9%) than its historical volatility (22.7%), indicating potential for a wide price swing in the next year. This uncertainty stems from a recent "cyber incident" that impacted Q1 earnings, despite management maintaining full-year guidance. The authors advise investors to assess their portfolio's exposure to this single-stock risk rather than attempting to predict its direction.

DA Davidson has reiterated a Buy rating and a $460 price target for Tyler Technologies Inc. (NYSE: TYL) after the company's investor day. Management updated its 2026 non-GAAP EPS guidance and fine-tuned 2030 revenue and margin goals, leading to an improved outlook despite the stock trading 32% down over the past six months and being considered undervalued by InvestingPro. Other analysts like Piper Sandler also maintain an Overweight rating, while Cantor Fitzgerald lowered its price target, reflecting mixed sentiments in the software-as-a-service sector.

Procter & Gamble's CFO, Andre Schulten, confirmed that the company is on track to cut over 3,500 non-manufacturing positions, representing more than half of the targeted 7,000 cuts, by the end of June 2026. This restructuring plan, announced a year prior, aims to improve sales by freeing up funds for product innovations. The cuts will affect 6.4% of P&G's global workforce, with a significant impact on its hometown workforce in Cincinnati.

Danaher Corporation has completed its acquisition of Masimo Corporation on June 10, 2026, integrating Masimo’s medical technology into Danaher's life sciences and diagnostics operations. This strategic move adds Masimo's non-invasive patient monitoring technologies and signal processing solutions to Danaher's portfolio. The financial terms of the deal were not disclosed, and integration processes are set to begin immediately.

William R. Berkley, the founder and executive chairman of Greenwich-based insurer W.R. Berkley Corp., has passed away at the age of 80. Berkley established the company in 1967 and built it into one of the nation's largest commercial property-and-casualty insurance organizations, operating 60 insurance and reinsurance businesses worldwide and employing thousands. Following his death, his son, W. Robert Berkley Jr., who serves as president and CEO, was appointed chairman of the board of directors.

The London Company Income Equity Strategy highlighted Dominion Energy, Inc. (NYSE: D) in its Q1 2026 investor letter, increasing its position due to consistent, regulated earnings and anticipated demand growth from data center expansion. The stock closed at $66.25 on June 9, 2026, and has shown a 19.22% gain over the past 52 weeks. While 37 hedge funds held D, the company suggests other AI stocks might offer greater upside and less risk.

Danaher Corporation has finalized its acquisition of Masimo Corporation, integrating Masimo's patient monitoring and pulse oximetry business into Danaher's diagnostics portfolio. This move strengthens Danaher's presence in acute care settings and expands its offering with established monitoring technologies and AI-enabled capabilities. Masimo will operate as a standalone subsidiary within Danaher's Diagnostics segment, benefiting from Danaher's global scale and resources while maintaining its brand and market presence.